Definitive Healthcare (NASDAQ:DH) Downgraded to Equal Weight at Morgan Stanley

Definitive Healthcare (NASDAQ:DH) was downgraded by investment analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Wednesday, MarketBeat Ratings reports. They currently have a $9.00 price objective on the stock, down from their prior price objective of $11.50. Morgan Stanley’s price target would suggest a potential upside of 74.08% from the stock’s current price.

DH has been the subject of several other reports. Stifel Nicolaus decreased their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, January 17th. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Canaccord Genuity Group boosted their price target on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Finally, Barclays raised their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a report on Friday, March 1st. Nine investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $9.94.

Definitive Healthcare Trading Down 3.4 %

Shares of NASDAQ:DH opened at $5.17 on Wednesday. The firm has a market cap of $608.97 million, a price-to-earnings ratio of -2.90, a PEG ratio of 6.12 and a beta of 1.41. Definitive Healthcare has a 12 month low of $4.38 and a 12 month high of $12.45. The company’s fifty day simple moving average is $7.61 and its 200 day simple moving average is $8.27. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The firm had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. As a group, research analysts forecast that Definitive Healthcare will post 0.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Tower Research Capital LLC TRC boosted its holdings in shares of Definitive Healthcare by 599.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock worth $58,000 after acquiring an additional 4,959 shares during the period. Norden Group LLC acquired a new position in Definitive Healthcare in the 1st quarter valued at $83,000. Berry Wealth Group LP bought a new position in Definitive Healthcare during the 1st quarter worth $99,000. Reynders McVeigh Capital Management LLC acquired a new stake in shares of Definitive Healthcare during the fourth quarter worth $129,000. Finally, Arizona State Retirement System increased its position in Definitive Healthcare by 13.6% during the fourth quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock worth $142,000 after acquiring an additional 1,701 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.